Literature DB >> 31272168

Transitions in pressure-amorphized clathrate hydrates akin to those of amorphous ices.

Ove Andersson1, Paulo H B Brant Carvalho2, Ying-Jui Hsu1, Ulrich Häussermann2.   

Abstract

Type II clathrate hydrates (CHs) were studied by thermal and dielectric measurements. All CHs amorphize, or collapse, on pressurization to 1.3 GPa below 135 K. After heating to 160 K at 1 GPa, the stability of the amorphous states increases in a process similar to the gradual high density to very high density amorphous ice (HDA to VHDA) transition. On a subsequent pressure decrease, the amorphized CHs expand partly irreversibly similar to the gradual VHDA to expanded HDA ice transformation. After further heating at 1 GPa, weak transition features appear near the HDA to low density amorphous ice transition. The results suggest that CH nucleation sites vanish on heating to 160 K at 1 GPa and that a sluggish partial phase-separation process commences on further heating. The collapsed CHs show two glass transitions (GTs), GT1 and GT2. GT1 is weakly pressure-dependent, 12 K GPa-1, with a relaxation time of 0.3 s at 140 K and 1 GPa; it is associated with a weak heat capacity increase of 3.7 J H2O-mol-1 K-1 in a 18 K range and an activation energy of only 38 kJ mol-1 at 1 GPa. The corresponding temperature of GT2 is 159 K at 0.4 GPa with a pressure dependence of 36 K GPa-1; it shows 5.5 times larger heat capacity increase and 4 times higher activation energy than GT1. GT1 is observed also in HDA and VHDA, whereas GT2 occurs just above the crystallization temperature of expanded HDA and only within its ∼0.2-0.7 GPa stable pressure range.

Entities:  

Year:  2019        PMID: 31272168     DOI: 10.1063/1.5096981

Source DB:  PubMed          Journal:  J Chem Phys        ISSN: 0021-9606            Impact factor:   3.488


  1 in total

1.  Structural investigation of three distinct amorphous forms of Ar hydrate.

Authors:  Paulo H B Brant Carvalho; Pedro Ivo R Moraes; Alexandre A Leitão; Ove Andersson; Chris A Tulk; Jamie Molaison; Alexander P Lyubartsev; Ulrich Häussermann
Journal:  RSC Adv       Date:  2021-09-15       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.